company background image
AKBM

Aker BioMarineOB:AKBM Stock Report

Market Cap

kr3.9b

7D

7.9%

1Y

-52.2%

Updated

23 Sep, 2021

Data

Company Financials +
AKBM fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health2/6
Dividends0/6

AKBM Overview

Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa.

Aker BioMarine Competitors

Neptune Wellness Solutions

TSX:NEPT

CA$120.9m

Acasti Pharma

TSXV:ACST

CA$120.5m

Price History & Performance

Summary of all time highs, changes and price drops for Aker BioMarine
Historical stock prices
Current Share Pricekr44.25
52 Week Highkr39.70
52 Week Lowkr129.08
Beta0
1 Month Change-12.03%
3 Month Change-42.75%
1 Year Change-52.16%
3 Year Changen/a
5 Year Changen/a
Change since IPO-57.74%

Recent News & Updates

Shareholder Returns

AKBMNO FoodNO Market
7D7.9%3.1%0.5%
1Y-52.2%16.7%25.9%

Return vs Industry: AKBM underperformed the Norwegian Food industry which returned 14.3% over the past year.

Return vs Market: AKBM underperformed the Norwegian Market which returned 22.8% over the past year.

Price Volatility

Is AKBM's price volatile compared to industry and market?
AKBM volatility
AKBM Beta0
Industry Beta0.50
Market Beta1

Stable Share Price: AKBM is more volatile than 75% of Norwegian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: AKBM's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Norwegian stocks.

About the Company

FoundedEmployeesCEOWebsite
n/a551Matts Johansenhttps://www.akerbiomarine.com

Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates in two segments, Ingredients and Brands. The company provides krill oil products, including omega-3s, phospholipids, choline, and astaxanthin under the Superba, Kori, NKO, and K·REAL brands.

Aker BioMarine Fundamentals Summary

How do Aker BioMarine's earnings and revenue compare to its market cap?
AKBM fundamental statistics
Market CapUS$451.76m
Earnings (TTM)-US$7.74m
Revenue (TTM)US$270.05m

1.7x

P/S Ratio

-58.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AKBM income statement (TTM)
RevenueUS$270.05m
Cost of RevenueUS$160.52m
Gross ProfitUS$109.53m
ExpensesUS$117.27m
Earnings-US$7.74m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Oct 29, 2021

Earnings per share (EPS)-0.093
Gross Margin40.56%
Net Profit Margin-2.87%
Debt/Equity Ratio84.4%

How did AKBM perform over the long term?

See historical performance and comparison

Valuation

Is Aker BioMarine undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: AKBM (NOK44.25) is trading below our estimate of fair value (NOK342.88)

Significantly Below Fair Value: AKBM is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: AKBM is unprofitable, so we can't compare its PE Ratio to the Norwegian Food industry average.

PE vs Market: AKBM is unprofitable, so we can't compare its PE Ratio to the Norwegian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AKBM's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AKBM is good value based on its PB Ratio (1.2x) compared to the NO Food industry average (2.5x).


Future Growth

How is Aker BioMarine forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

91.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AKBM is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.2%).

Earnings vs Market: AKBM is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: AKBM's is expected to become profitable in the next 3 years.

Revenue vs Market: AKBM's revenue (13.4% per year) is forecast to grow faster than the Norwegian market (5.7% per year).

High Growth Revenue: AKBM's revenue (13.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: AKBM's Return on Equity is forecast to be low in 3 years time (7.2%).


Past Performance

How has Aker BioMarine performed over the past 5 years?

-19.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AKBM is currently unprofitable.

Growing Profit Margin: AKBM is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: AKBM is unprofitable, and losses have increased over the past 5 years at a rate of 19.9% per year.

Accelerating Growth: Unable to compare AKBM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AKBM is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (33.1%).


Return on Equity

High ROE: AKBM has a negative Return on Equity (-2.11%), as it is currently unprofitable.


Financial Health

How is Aker BioMarine's financial position?


Financial Position Analysis

Short Term Liabilities: AKBM's short term assets ($247.3M) exceed its short term liabilities ($77.3M).

Long Term Liabilities: AKBM's short term assets ($247.3M) do not cover its long term liabilities ($325.2M).


Debt to Equity History and Analysis

Debt Level: AKBM's debt to equity ratio (84.4%) is considered high.

Reducing Debt: AKBM's debt to equity ratio has reduced from 215.9% to 84.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AKBM has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if AKBM has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Aker BioMarine current dividend yield, its reliability and sustainability?

1.84%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AKBM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AKBM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AKBM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AKBM's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AKBM's dividend in 3 years as they are not forecast to pay a notable one for the Norwegian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.5yrs

Average management tenure


CEO

Matts Johansen (45 yo)

6.17yrs

Tenure

US$630,000

Compensation

Mr. Matts Johansen has been Chief Executive Officer at Aker BioMarine ASA since July 1, 2015. Mr. Johansen has been Chief Operating Officer of Aker Biomarine Antarctic AS since June 1, 2012. He serves as P...


CEO Compensation Analysis

Compensation vs Market: Matts's total compensation ($USD630.00K) is about average for companies of similar size in the Norwegian market ($USD616.98K).

Compensation vs Earnings: Matts's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: AKBM's management team is seasoned and experienced (5.5 years average tenure).


Board Members

Experienced Board: AKBM's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: AKBM insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Aker BioMarine AS's employee growth, exchange listings and data sources


Key Information

  • Name: Aker BioMarine AS
  • Ticker: AKBM
  • Exchange: OB
  • Founded: NaN
  • Industry: Packaged Foods and Meats
  • Sector: Food, Beverage & Tobacco
  • Market Cap: kr3.876b
  • Shares outstanding: 87.59m
  • Website: https://www.akerbiomarine.com

Number of Employees


Location

  • Aker BioMarine AS
  • Oksenøyveien 10
  • PO Box 496
  • Lysaker
  • Akershus
  • 1327
  • Norway

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/23 21:37
End of Day Share Price2021/09/23 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.